Health ❯Medicine ❯Clinical Trials
mRNA-1083 Trials TRAILBLAZER-ALZ 2 FDA Approval Process MONeT Trial Cancer Vaccine Trials
The vaccine, tailored to individual patients' cancer profiles, shows potential to dramatically reduce melanoma recurrence and death rates.